Rosette Lidereau

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ghiringhelli François; Apetoh Lionel; Tesniere Antoine; Aymeric Laetitia; Ma Yuting; Ortiz Carla; Vermaelen Karim; Panaretakis Theocharis; Mignot Grégoire; Ullrich Evelyn; Perfettini Jean-Luc; Schlemmer Frédéric; Tasdemir Ezgi; Uhl Martin; Génin Pierre; Civas Ahmet; Ryffel Bernhard; Kanellopoulos Jean; Tschopp Jürg; André Fabrice; Lidereau Rosette; McLaughlin Nicole M; Haynes Nicole M; Smyth Mark J; Kroemer Guido; Zitvogel Laurence
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.
Bouteille N; Driouch K; Hage P El; Sin S; Formstecher E; Camonis J; Lidereau R; Lallemand F
Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein.
Rouleau Etienne; Lefol Cédrick; Bourdon Violaine; Coulet Florence; Noguchi Tetsuro; Soubrier Florent; Bièche Ivan; Olschwang Sylviane; Sobol Hagay; Lidereau Rosette
Quantitative PCR high-resolution melting (qPCR-HRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application to MLH1 germline mutations in Lynch syndrome.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Rosette Lidereau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ghiringhelli François; Apetoh Lionel; Tesniere Antoine; Aymeric Laetitia; Ma Yuting; Ortiz Carla; Vermaelen Karim; Panaretakis Theocharis; Mignot Grégoire; Ullrich Evelyn; Perfettini Jean-Luc; Schlemmer Frédéric; Tasdemir Ezgi; Uhl Martin; Génin Pierre; Civas Ahmet; Ryffel Bernhard; Kanellopoulos Jean; Tschopp Jürg; André Fabrice; Lidereau Rosette; McLaughlin Nicole M; Haynes Nicole M; Smyth Mark J; Kroemer Guido; Zitvogel Laurence
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.
Nature medicine 2009;15(10):1170-8.
2009: Bouteille N; Driouch K; Hage P El; Sin S; Formstecher E; Camonis J; Lidereau R; Lallemand F
Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein.
Oncogene 2009;28(28):2569-80.
2009: Rouleau Etienne; Lefol Cédrick; Bourdon Violaine; Coulet Florence; Noguchi Tetsuro; Soubrier Florent; Bièche Ivan; Olschwang Sylviane; Sobol Hagay; Lidereau Rosette
Quantitative PCR high-resolution melting (qPCR-HRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application to MLH1 germline mutations in Lynch syndrome.
Human mutation 2009;30(6):867-75.
2009: Ghayad Sandra E; Vendrell Julie A; Bieche Ivan; Spyratos Frédérique; Dumontet Charles; Treilleux Isabelle; Lidereau Rosette; Cohen Pascale A
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer.
Journal of molecular endocrinology 2009;42(2):87-103.
2009: Manié Elodie; Vincent-Salomon Anne; Lehmann-Che Jacqueline; Pierron Gaelle; Turpin Elisabeth; Warcoin Mathilde; Gruel Nadège; Lebigot Ingrid; Sastre-Garau Xavier; Lidereau Rosette; Remenieras Audrey; Feunteun Jean; Delattre Olivier; de Thé Hugues; Stoppa-Lyonnet Dominique; Stern Marc-Henri
High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors.
Cancer research 2009;69(2):663-71.
2008: Julié Catherine; Trésallet Christophe; Brouquet Antoine; Vallot Céline; Zimmermann Ute; Mitry Emmanuel; Radvanyi François; Rouleau Etienne; Lidereau Rosette; Coulet Florence; Olschwang Sylviane; Frébourg Thierry; Rougier Philippe; Nordlinger Bernard; Laurent-Puig Pierre; Penna Christophe; Boileau Catherine; Franc Brigitte; Muti Christine; Hofmann-Radvanyi Hélène
Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
The American journal of gastroenterology 2008;103(11):2825-35; quiz 2836.
2008: Ghayad Sandra E; Bieche Ivan; Vendrell Julie A; Keime Celine; Lidereau Rosette; Dumontet Charles; Cohen Pascale A
mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels.
Cancer science 2008;99(10):1992-2003.
2008: Shehata Mona; Bièche Ivan; Boutros Rose; Weidenhofer Judith; Fanayan Susan; Spalding Lisa; Zeps Nikolajs; Byth Karen; Bright Robert K; Lidereau Rosette; Byrne Jennifer A
Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5050-60.
2008: Landemaine Thomas; Jackson Amanda; Bellahcène Akeila; Rucci Nadia; Sin Soraya; Abad Berta Martin; Sierra Angels; Boudinet Alain; Guinebretière Jean-Marc; Ricevuto Enrico; Noguès Catherine; Briffod Marianne; Bièche Ivan; Cherel Pascal; Garcia Teresa; Castronovo Vincent; Teti Anna; Lidereau Rosette; Driouch Keltouma
A six-gene signature predicting breast cancer lung metastasis.
Cancer research 2008;68(15):6092-9.
2008: Anczuków Olga; Buisson Monique; Salles Marie-Josèphe; Triboulet Sarah; Longy Michel; Lidereau Rosette; Sinilnikova Olga M; Mazoyer Sylvie
Unclassified variants identified in BRCA1 exon 11: Consequences on splicing.
Genes, chromosomes & cancer 2008;47(5):418-26.
2008: Honorat Mylène; Mesnier Aurelia; Vendrell Julie; Guitton Jérôme; Bieche Ivan; Lidereau Rosette; Kruh Gary D; Dumontet Charles; Cohen Pascale; Payen Lea
ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells.
Endocrine-related cancer 2008;15(1):125-38.
2008: Fritah Asmaà; Saucier Cécile; De Wever Olivier; Bracke Marc; Bièche Ivan; Lidereau Rosette; Gespach Christian; Drouot Sylvain; Redeuilh Gérard; Sabbah Michèle
Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells.
Molecular and cellular biology 2008;28(3):1114-23.
2008: Lerebours Florence; Vacher Sophie; Andrieu Catherine; Espie Marc; Marty Michel; Lidereau Rosette; Bieche Ivan
NF-kappa B genes have a major role in inflammatory breast cancer.
BMC cancer 2008;8():41.
2007: Bièche Ivan; Chavey Carine; Andrieu Catherine; Busson Muriel; Vacher Sophie; Le Corre Ludovic; Guinebretière Jean-Marc; Burlinchon Sandrine; Lidereau Rosette; Lazennec Gwendal
CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
Endocrine-related cancer 2007;14(4):1039-52.
2007: Apetoh Lionel; Ghiringhelli François; Tesniere Antoine; Criollo Alfredo; Ortiz Carla; Lidereau Rosette; Mariette Christophe; Chaput Nathalie; Mira Jean-Paul; Delaloge Suzette; André Fabrice; Tursz Thomas; Kroemer Guido; Zitvogel Laurence
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.
Immunological reviews 2007;220():47-59.
2007: Mottet Denis; Bellahcène Akeila; Pirotte Sophie; Waltregny David; Deroanne Christophe; Lamour Virginie; Lidereau Rosette; Castronovo Vincent
Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis.
Circulation research 2007;101(12):1237-46.
2007: Marot Didier; Bieche Ivan; Aumas Chantal; Esselin Stéphanie; Bouquet Céline; Vacher Sophie; Lazennec Gwendal; Perricaudet Michel; Kuttenn Frederique; Lidereau Rosette; de Roux Nicolas
High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Endocrine-related cancer 2007;14(3):691-702.
2007: Buijs Jeroen T; Henriquez Nico V; van Overveld Petra G M; van der Horst Geertje; Que Ivo; Schwaninger Ruth; Rentsch Cyrill; Ten Dijke Peter; Cleton-Jansen Anne-Marie; Driouch Keltouma; Lidereau Rosette; Bachelier Richard; Vukicevic Slobodan; Clézardin Philippe; Papapoulos Socrates E; Cecchini Marco G; Löwik Clemens W G M; van der Pluijm Gabri
Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Cancer research 2007;67(18):8742-51.
2007: Rouleau E; Lefol C; Tozlu S; Andrieu C; Guy C; Copigny F; Nogues C; Bieche I; Lidereau R
High-resolution oligonucleotide array-CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1.
Clinical genetics 2007;72(3):199-207.
2007: Apetoh Lionel; Ghiringhelli François; Tesniere Antoine; Obeid Michel; Ortiz Carla; Criollo Alfredo; Mignot Grégoire; Maiuri M Chiara; Ullrich Evelyn; Saulnier Patrick; Yang Huan; Amigorena Sebastian; Ryffel Bernard; Barrat Franck J; Saftig Paul; Levi Francis; Lidereau Rosette; Nogues Catherine; Mira Jean-Paul; Chompret Agnès; Joulin Virginie; Clavel-Chapelon Françoise; Bourhis Jean; André Fabrice; Delaloge Suzette; Tursz Thomas; Kroemer Guido; Zitvogel Laurence
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Nature medicine 2007;13(9):1050-9.
2007: Bièche Ivan; Narjoz Cèline; Asselah Tarik; Vacher Sophie; Marcellin Patrick; Lidereau Rosette; Beaune Philippe; de Waziers Isabelle
Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues.
Pharmacogenetics and genomics 2007;17(9):731-42.
2007: Desmedt Christine; Piette Fanny; Loi Sherene; Wang Yixin; Lallemand Françoise; Haibe-Kains Benjamin; Viale Giuseppe; Delorenzi Mauro; Zhang Yi; d'Assignies Mahasti Saghatchian; Bergh Jonas; Lidereau Rosette; Ellis Paul; Harris Adrian L; Klijn Jan G M; Foekens John A; Cardoso Fatima; Piccart Martine J; Buyse Marc; Sotiriou Christos;
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3207-14.
2007: Bellahcène A; Bachelier R; Detry C; Lidereau R; Clézardin P; Castronovo V
Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells.
Breast cancer research and treatment 2007;101(2):135-48.
2007: Sanz Rebeca; Aragüés Ramón; Stresing Verena; Martín Berta; Landemaine Thomas; Oliva Baldo; Driouch Keltouma; Lidereau Rosette; Sierra Angels
Functional pathways shared by liver and lung metastases: a mitochondrial chaperone machine is up-regulated in soft-tissue breast cancer metastasis.
Clinical & experimental metastasis 2007;24(8):673-83.
2007: Driouch Keltouma; Landemaine Thomas; Sin Soraya; Wang ShaoXiao; Lidereau Rosette
Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis.
Clinical & experimental metastasis 2007;24(8):575-85.
2006: Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
Endocrine-related cancer 2006;13(4):1109-20.
2006: Di Benedetto M; Bièche I; Deshayes F; Vacher S; Nouet S; Collura V; Seitz I; Louis S; Pineau P; Amsellem-Ouazana D; Couraud P O; Strosberg A D; Stoppa-Lyonnet D; Lidereau R; Nahmias C
Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP.
Gene 2006;380(2):127-36.
2006: Buyse Marc; Loi Sherene; van't Veer Laura; Viale Giuseppe; Delorenzi Mauro; Glas Annuska M; d'Assignies Mahasti Saghatchian; Bergh Jonas; Lidereau Rosette; Ellis Paul; Harris Adrian; Bogaerts Jan; Therasse Patrick; Floore Arno; Amakrane Mohamed; Piette Fanny; Rutgers Emiel; Sotiriou Christos; Cardoso Fatima; Piccart Martine J;
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.
Journal of the National Cancer Institute 2006;98(17):1183-92.
2006: Girault Igor; Bièche Ivan; Lidereau Rosette
Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.
Maturitas 2006;54(4):342-51.
2006: Amsellem-Ouazana Delphine; Bièche Ivan; Molinié Vincent; Elie Caroline; Vieillefond Annick; Tozlu Sengül; Botto Henry; Debré Bernard; Lidereau Rosette
Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
European urology 2006;49(6):1035-42; discussion 1042-3.
2006: Amsellem-Ouazana Delphine; Bièche Ivan; Tozlu Sengül; Botto Henry; Debré Bernard; Lidereau Rosette
Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder.
The Journal of urology 2006;175(3 Pt 1):1127-32.
2006: Olivier Magali; Langerød Anita; Carrieri Patrizia; Bergh Jonas; Klaar Sigrid; Eyfjord Jorunn; Theillet Charles; Rodriguez Carmen; Lidereau Rosette; Bièche Ivan; Varley Jennifer; Bignon Yves; Uhrhammer Nancy; Winqvist Robert; Jukkola-Vuorinen Arja; Niederacher Dieter; Kato Shunsuke; Ishioka Chikashi; Hainaut Pierre; Børresen-Dale Anne-Lise
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1157-67.
2005: Amsellem-Ouazana Delphine; Goldwasser François; Bieche Ivan; Lidereau Rosette; Zerbib Marc
[Anti-ErbB targeted therapy and urothelial tumors]
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2005;15(6 Suppl 1):1229-35.
2005: Girault Igor; Rougier Nathalie; Chesné Christophe; Lidereau Rosette; Beaune Philippe; Bieche Ivan; de Waziers Isabelle
Simultaneous measurement of 23 isoforms from the human cytochrome P450 families 1 to 3 by quantitative reverse transcriptase-polymerase chain reaction.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(12):1803-10.
2005: Bossard Céline; Bieche Ivan; Le Doussal Viviane; Lidereau Rosette; Sabourin Jean Christophe
Real-time RT-PCR: a complementary method to detect HER-2 status in breast carcinoma.
Anticancer research 2005;25(6C):4679-83.
2005: Hughes David J; Ginolhac Sophie M; Coupier Isabelle; Barjhoux Laure; Gaborieau Valérie; Bressac-de-Paillerets Brigitte; Chompret Agnès; Bignon Yves-Jean; Uhrhammer Nancy; Lasset Christine; Giraud Sophie; Sobol Hagay; Hardouin Agnès; Berthet Pascaline; Peyrat Jean-Philippe; Fournier Joelle; Nogues Catherine; Lidereau Rosette; Muller Danièle; Fricker Jean-Pierre; Longy Michel; Toulas Christine; Guimbaud Rosine; Yannoukakos Drakoulis; Mazoyer Sylvie; Lynch Henry T; Lenoir Gilbert M; Goldgar David E; Stoppa-Lyonnet Dominique; Sinilnikova Olga M
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
International journal of cancer. Journal international du cancer 2005;117(2):230-3.
2005: Vendrell J A; Bieche I; Desmetz C; Badia E; Tozlu S; Nguyen C; Nicolas J C; Lidereau R; Cohen P A
Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.
Endocrine-related cancer 2005;12(1):75-92.
2005: Lerebours Florence; Bieche Ivan; Lidereau Rosette
Update on inflammatory breast cancer.
Breast cancer research : BCR 2005;7(2):52-8.
2004: Bièche Ivan; Tozlu Sengül; Girault Igor; Lidereau Rosette
Identification of a three-gene expression signature of poor-prognosis breast carcinoma.
Molecular cancer 2004;3(1):37.
2004: Richard Stéphane; Lidereau Rosette; Giraud Sophie
The growing family of hereditary renal cell carcinoma.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(12):2954-8.
2004: Tournier Isabelle; Paillerets Brigitte Bressac-de; Sobol Hagay; Stoppa-Lyonnet Dominique; Lidereau Rosette; Barrois Michel; Mazoyer Sylvie; Coulet Florence; Hardouin Agnès; Chompret Agnès; Lortholary Alain; Chappuis Pierre; Bourdon Violaine; Bonadona Valérie; Maugard Christine; Gilbert Brigitte; Nogues Catherine; Frébourg Thierry; Tosi Mario
Significant contribution of germline BRCA2 rearrangements in male breast cancer families.
Cancer research 2004;64(22):8143-7.
2004: Girault Igor; Andrieu Catherine; Tozlu Sengül; Spyratos Fréderique; Bièche Ivan; Lidereau Rosette
Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.
Cancer letters 2004;215(1):101-12.
2004: Bièche Ivan; Lerebours Florence; Tozlu Sengül; Espie Marc; Marty Michel; Lidereau Rosette
Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6789-95.
2004: de Cremoux P; Bieche I; Tran-Perennou C; Vignaud S; Boudou E; Asselain B; Lidereau R; Magdelénat H; Becette V; Sigal-Zafrani B; Spyratos F
Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction.
Endocrine-related cancer 2004;11(3):489-95.
2004: Skrzypczak Maciej; Bieche Ivan; Szymczak Sylwia; Tozlu Sengul; Lewandowski Sebastian; Girault Igor; Radwanska Katarzyna; Szczylik Cezary; Jakowicki Jerzy A; Lidereau Rosette; Kaczmarek Leszek
Evaluation of mRNA expression of estrogen receptor beta and its isoforms in human normal and neoplastic endometrium.
International journal of cancer. Journal international du cancer 2004;110(6):783-7.
2004: Bièche Ivan; Tozlu Sengül; Girault Igor; Onody Peter; Driouch Keltouma; Vidaud Michel; Lidereau Rosette
Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression.
Carcinogenesis 2004;25(3):405-11.
2004: Barrois M; Bièche I; Mazoyer S; Champème M-H; Bressac-de Paillerets B; Lidereau R
Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families.
Clinical genetics 2004;65(2):131-6.
2004: Bièche Ivan; Girault Igor; Urbain Estelle; Tozlu Sengül; Lidereau Rosette
Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.
Breast cancer research : BCR 2004;6(3):R252-63.
2003: Girault Igor; Tozlu Sengül; Lidereau Rosette; Bièche Ivan
Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4415-22.
2003: Lerebours Florence; Bertheau Philippe; Bieche Ivan; Plassa Louis-François; Champeme Marie-Helene; Hacene Kamel; Toulas Christine; Espie Marc; Marty Michel; Lidereau Rosette
Two prognostic groups of inflammatory breast cancer have distinct genotypes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4184-9.
2003: Bièche Ivan; Onody Peter; Tozlu Sengül; Driouch Keltouma; Vidaud Michel; Lidereau Rosette
Prognostic value of ERBB family mRNA expression in breast carcinomas.
International journal of cancer. Journal international du cancer 2003;106(5):758-65.
2003: Gad Sophie; Bièche Ivan; Barrois Michel; Casilli Federica; Pages-Berhouet Sabine; Dehainault Catherine; Gauthier-Villars Marion; Bensimon Aaron; Aurias Alain; Lidereau Rosette; Bressac-de Paillerets Brigitte; Tosi Mario; Mazoyer Sylvie; Stoppa-Lyonnet Dominique
Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family.
Human mutation 2003;21(6):654.
2003: Longchampt Elisabeth; Lebret Thierry; Molinie Vincent; Bieche Ivan; Botto Henry; Lidereau Rosette
[Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2003;13(2):238-45.
2003: Girault Igor; Lerebours Florence; Amarir Samira; Tozlu Sengül; Tubiana-Hulin Michèle; Lidereau Rosette; Bièche Ivan
Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1259-66.
2003: Bièche I; Girault I; Sabourin J-C; Tozlu S; Driouch K; Vidaud M; Lidereau R
Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
British journal of cancer 2003;88(6):863-70.
2002: Lerebours Florence; Bertheau Philippe; Bieche Ivan; Driouch Keltouma; De The Hugues; Hacene Kamel; Espie Marc; Marty Michel; Lidereau Rosette
Evidence of chromosome regions and gene involvement in inflammatory breast cancer.
International journal of cancer. Journal international du cancer 2002;102(6):618-22.
2002: Girault I; Lerebours F; Tozlu S; Spyratos F; Tubiana-Hulin M; Lidereau R; Bièche I
Real-time reverse transcription PCR assay of CYP19 expression: application to a well-defined series of post-menopausal breast carcinomas.
The Journal of steroid biochemistry and molecular biology 2002;82(4-5):323-32.
2002: Turpin Elizabeth; Bièche Ivan; Bertheau Philippe; Plassa Louis-François; Lerebours Florence; de Roquancourt Anne; Olivi Martine; Espié Marc; Marty Michel; Lidereau Rosette; Vidaud Michel; de Thé Hughes
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer.
Oncogene 2002;21(49):7593-7.
2002: Spyratos Frederique; Bouchet Cecile; Tozlu Sengul; Labroquere Marc; Vignaud Sophie; Becette Veronique; Lidereau Rosette; Bieche Ivan
Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer.
Anticancer research 2002;22(5):2997-3003.
2002: Bièche Ivan; Latil Alain; Parfait Béatrice; Vidaud Dominique; Laurendeau Ingrid; Lidereau Rosette; Cussenot Olivier; Vidaud Michel
CGA gene (coding for the alpha subunit of glycoprotein hormones) overexpression in ER alpha-positive prostate tumors.
European urology 2002;41(3):335-41.
2002: Driouch Keltouma; Prydz Hans; Monese Rossana; Johansen Henning; Lidereau Rosette; Frengen Eirik
Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
Oncogene 2002;21(12):1832-40.
2002: Farabegoli Fulvia; Champeme Marie-Helene; Bieche Ivan; Santini Donatella; Ceccarelli Claudio; Derenzini Massimo; Lidereau Rosette
Genetic pathways in the evolution of breast ductal carcinoma in situ.
The Journal of pathology 2002;196(3):280-6.
2002: Bièche I; Olivi M; Noguès C; Vidaud M; Lidereau R
Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays.
British journal of cancer 2002;86(4):580-6.
2001: Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R
Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
Oncogene 2001;20(56):8109-15.
2001: Bièche I; Onody P; Lerebours F; Tozlu S; Hacene K; Andrieu C; Vidaud M; Tubiana-Hulin M; Spyratos F; Lidereau R
ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinoma.
Cancer letters 2001;174(2):173-8.
2001: Bièche I; Parfait B; Noguès C; Andrieu C; Vidaud D; Spyratos F; Lidereau R; Vidaud M
The CGA gene as new predictor of the response to endocrine therapy in ER alpha-positive postmenopausal breast cancer patients.
Oncogene 2001;20(47):6955-9.
2001: Bertheau P; Plassa L F; Lerebours F; de Roquancourt A; Turpin E; Lidereau R; de Thé H; Janin A
Allelic loss detection in inflammatory breast cancer: improvement with laser microdissection.
Laboratory investigation; a journal of technical methods and pathology 2001;81(10):1397-402.
2001: Bièche I; Parfait B; Tozlu S; Lidereau R; Vidaud M
Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene.
Carcinogenesis 2001;22(9):1521-6.
2001: de Pinieux G; Legrier M E; Poirson-Bichat F; Courty Y; Bras-Gonçalves R; Dutrillaux A M; Némati F; Oudard S; Lidereau R; Broqua P; Junien J L; Dutrillaux B; Poupon M F
Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach.
The American journal of pathology 2001;159(2):753-64.
2001: Giovangrandi Y; Parfait B; Asheuer M; Olivi M; Lidereau R; Vidaud M; Bièche I
Analysis of the human CGB/LHB gene cluster in breast tumors by real-time quantitative RT-PCR assays.
Cancer letters 2001;168(1):93-100.
2001: Onody P; Bertrand F; Muzeau F; Bièche I; Lidereau R
Fluorescence in situ hybridization and immunohistochemical assays for HER-2/neu status determination: application to node-negative breast cancer.
Archives of pathology & laboratory medicine 2001;125(6):746-50.
2001: Bieche I; Parfait B; Le Doussal V; Olivi M; Rio M C; Lidereau R; Vidaud M
Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.
Cancer research 2001;61(4):1652-8.
2000: Latil A; Vidaud D; Valéri A; Fournier G; Vidaud M; Lidereau R; Cussenot O; Biàche I
htert expression correlates with MYC over-expression in human prostate cancer.
International journal of cancer. Journal international du cancer 2000;89(2):172-6.
2000: Latil A; Bièche I; Pesche S; Valéri A; Fournier G; Cussenot O; Lidereau R
VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms.
International journal of cancer. Journal international du cancer 2000;89(2):167-71.
2000: Lidereau R; Eisinger F; Champème M H; Noguès C; Bièche I; Birnbaum D; Pallud C; Jacquemier J; Sobol H
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer.
Cancer research 2000;60(5):1206-10.
2000: Bièche I; Noguès C; Paradis V; Olivi M; Bedossa P; Lidereau R; Vidaud M
Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):452-9.
2000: Curmi P A; Noguès C; Lachkar S; Carelle N; Gonthier M P; Sobel A; Lidereau R; Bièche I
Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.
British journal of cancer 2000;82(1):142-50.
1999: Bièche I; Noguès C; Lidereau R
Overexpression of BRCA2 gene in sporadic breast tumours.
Oncogene 1999;18(37):5232-8.
1999: Jacquemier J; Eisinger F; Noguès C; Sun Z Z; Guinebretière J M; Peyrat J P; Geneix J; Lidereau R; Birnbaum D; Sobol H
Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers.
International journal of cancer. Journal international du cancer 1999;83(1):45-9.
1999: Bièche I; Champème M H; Lidereau R
Infrequent mutations of the MET gene in sporadic breast tumours.
International journal of cancer. Journal international du cancer 1999;82(6):908-10.
1999: Latil A; Pesche S; Valéri A; Fournier G; Cussenot O; Lidereau R
Expression and mutational analysis of the MADR2/Smad2 gene in human prostate cancer.
The Prostate 1999;40(4):225-31.
1999: Bièche I; Onody P; Laurendeau I; Olivi M; Vidaud D; Lidereau R; Vidaud M
Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications.
Clinical chemistry 1999;45(8 Pt 1):1148-56.
1999: Latil A; Bièche I; Pesche S; Volant A; Valèri A; Fournier G; Cussenot O; Lidereau R
Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer.
Human pathology 1999;30(7):809-15.
1999: Bièche I; Laurendeau I; Tozlu S; Olivi M; Vidaud D; Lidereau R; Vidaud M
Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.
Cancer research 1999;59(12):2759-65.
1999: Eisinger F; Noguès C; Guinebretière J M; Peyrat J P; Bardou V J; Noguchi T; Vennin P; Sauvan R; Lidereau R; Birnbaum D; Jacquemier J; Sobol H
Novel indications for BRCA1 screening using individual clinical and morphological features.
International journal of cancer. Journal international du cancer 1999;84(3):263-7.
1999: Bièche I; Lidereau R
Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue.
Cancer research 1999;59(11):2546-50.
1999: Bièche I; Khodja A; Lidereau R
Deletion mapping of chromosomal region 1p32-pter in primary breast cancer.
Genes, chromosomes & cancer 1999;24(3):255-63.
1999: Latil A; Pesche S; Valeri A; Cussenot O; Fournier G; Lidereau R
Common delta2 and delta8 RB1 variants in human breast and prostate tissues.
International journal of cancer. Journal international du cancer 1999;80(4):632-3.
1998: Bièche I; Latil A; Becette V; Lidereau R
Study of FHIT transcripts in normal and malignant breast tissue.
Genes, chromosomes & cancer 1998;23(4):292-9.
1998: Bièche I; Olivi M; Champème M H; Vidaud D; Lidereau R; Vidaud M
Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer.
International journal of cancer. Journal international du cancer 1998;78(5):661-6.
1998: Bièche I; Lachkar S; Becette V; Cifuentes-Diaz C; Sobel A; Lidereau R; Curmi P A
Overexpression of the stathmin gene in a subset of human breast cancer.
British journal of cancer 1998;78(6):701-9.
1998: Adélaïde J; Chaffanet M; Imbert A; Allione F; Geneix J; Popovici C; van Alewijk D; Trapman J; Zeillinger R; Børresen-Dale A L; Lidereau R; Birnbaum D; Pébusque M J
Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer.
Genes, chromosomes & cancer 1998;22(3):186-99.
1998: Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
Oncogene 1998;16(22):2879-83.
1998: Berthon P; Valeri A; Cohen-Akenine A; Drelon E; Paiss T; Wöhr G; Latil A; Millasseau P; Mellah I; Cohen N; Blanché H; Bellané-Chantelot C; Demenais F; Teillac P; Le Duc A; de Petriconi R; Hautmann R; Chumakov I; Bachner L; Maitland N J; Lidereau R; Vogel W; Fournier G; Mangin P; Cussenot O
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.
American journal of human genetics 1998;62(6):1416-24.
1998: Driouch K; Briffod M; Bièche I; Champème M H; Lidereau R
Location of several putative genes possibly involved in human breast cancer progression.
Cancer research 1998;58(10):2081-6.
1998: Latil A; Bièche I; Fournier G; Cussenot O; Pesche S; Lidereau R
Molecular analysis of the FHIT gene in human prostate cancer.
Oncogene 1998;16(14):1863-8.
1998: Bièche I; Lazar V; Noguès C; Poynard T; Giovangrandi Y; Bellet D; Lidereau R; Vidaud M
Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):671-6.
1998: Phelan C M; Borg A; Cuny M; Crichton D N; Baldersson T; Andersen T I; Caligo M A; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon Y J; Scherneck S; Barkardottir R; Borresen-Dale A L; Eyfjörd J; Theillet C; Thompson A M; Larsson C
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Cancer research 1998;58(5):1004-12.
1998: Zhou X P; Hoang J M; Li Y J; Seruca R; Carneiro F; Sobrinho-Simoes M; Lothe R A; Gleeson C M; Russell S E; Muzeau F; Fléjou J F; Hoang-Xuan K; Lidereau R; Thomas G; Hamelin R
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites.
Genes, chromosomes & cancer 1998;21(2):101-7.
1998: Wang Q; Driouch K; Courtois S; Champème M H; Bièche I; Treilleux I; Briffod M; Rimokh R; Magaud J P; Curmi P; Lidereau R; Puisieux A
Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers.
Oncogene 1998;16(5):677-9.
1998: Bieche I; Khodja A; Lidereau R
Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma.
Oncology reports 1998;5(1):267-72.
1997: Driouch K; Dorion-Bonnet F; Briffod M; Champéme M H; Longy M; Lidereau R
Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.
Genes, chromosomes & cancer 1997;19(3):185-91.
1997: Bièche I; Khodja A; Driouch K; Lidereau R
Genetic alteration mapping on chromosome 7 in primary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(6):1009-16.
1997: Serova-Sinilnikova O M; Boutrand L; Stoppa-Lyonnet D; Bressac-de-Paillerets B; Dubois V; Lasset C; Janin N; Bignon Y J; Longy M; Maugard C; Lidereau R; Leroux D; Frebourg T; Mazoyer S; Lenoir G M
BRCA2 mutations in hereditary breast and ovarian cancer in France.
American journal of human genetics 1997;60(5):1236-9.
1997: Devilee P; Hermans J; Eyfjörd J; Bøorresen A L; Lidereau R; Sobol H; Borg A; Cleton-Jansen A M; Oláh E; Cohen B B; Scherneck S; Hamann U; Peterlin B; Caligo M; Bignon Y J; Maugard C
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
Genes, chromosomes & cancer 1997;18(3):193-9.
1997: Bellet D; Lazar V; Bièche I; Paradis V; Giovangrandi Y; Paterlini P; Lidereau R; Bedossa P; Bidart J M; Vidaud M
Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cells.
Cancer research 1997;57(3):516-23.
1997: Bièche I; Noguès C; Rivoilan S; Khodja A; Latil A; Lidereau R
Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.
British journal of cancer 1997;76(11):1416-8.
1997: Driouch K; Champème M H; Beuzelin M; Bièche I; Lidereau R
Classical gene amplifications in human breast cancer are not associated with distant solid metastases.
British journal of cancer 1997;76(6):784-7.
1996: Lidereau R
[Potential genetic markers for prognosis and therapeutic response]
Bulletin du cancer 1996;83(12):1040.
1996: Latil A; Fournier G; Cussenot O; Lidereau R
Differential chromosome allelic imbalance in the progression of human prostate cancer.
The Journal of urology 1996;156(6):2079-83.
1996: Bièche I; Tomasetto C; Régnier C H; Moog-Lutz C; Rio M C; Lidereau R
Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
Cancer research 1996;56(17):3886-90.
1996: Bièche I; de Murcia G; Lidereau R
Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(7):1163-7.
1996: Latil A; Cussenot O; Fournier G; Lidereau R
The BRCA2 gene is not relevant to sporadic prostate tumours.
International journal of cancer. Journal international du cancer 1996;66(2):282-3.
1996: Scholl S M; Lidereau R; de la Rochefordière A; Le-Nir C C; Mosseri V; Noguès C; Pouillart P; Stanley F R
Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.
Breast cancer research and treatment 1996;39(3):275-83.
1995: Bièche I; Lidereau R
Genetic alterations in breast cancer.
Genes, chromosomes & cancer 1995;14(4):227-51.
1995: Latil A; Cussenot O; Fournier G; Baron J C; Lidereau R
Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(11):1385-9.
1995: Tomasetto C; Régnier C; Moog-Lutz C; Mattei M G; Chenard M P; Lidereau R; Basset P; Rio M C
Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17.
Genomics 1995;28(3):367-76.
1995: Latil A; Baron J C; Cussenot O; Fournier G; Soussi T; Boccon-Gibod L; Le Duc A; Rouëssé J; Lidereau R
[Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q]
Bulletin du cancer 1995;82(7):589-97.
1995: Champème M H; Bièche I; Beuzelin M; Lidereau R
Loss of heterozygosity on 7q31 occurs early during breast tumorigenesis.
Genes, chromosomes & cancer 1995;12(4):304-6.
1995: Kerangueven F; Essioux L; Dib A; Noguchi T; Allione F; Geneix J; Longy M; Lidereau R; Eisinger F; Pébusque M J
Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8.
Oncogene 1995;10(5):1023-6.
1995: Champème M H; Bièche I; Lizard S; Lidereau R
11q13 amplification in local recurrence of human primary breast cancer.
Genes, chromosomes & cancer 1995;12(2):128-33.
1995: Bièche I; Champème M H; Lidereau R
Loss and gain of distinct regions of chromosome 1q in primary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(1):123-7.
1995: Lidereau R; Nogues C
[Genetics and cancer: application to the breast]
Archives d'anatomie et de cytologie pathologiques 1995;43(1-2):5-11.
1995: Fournier G; Latil A; Amet Y; Abalain J H; Volant A; Mangin P; Floch H H; Lidereau R
Gene amplifications in advanced-stage human prostate cancer.
Urological research 1995;22(6):343-7.
1994: Champème M H; Bièche I; Hacène K; Lidereau R
Oncogene amplification per se: an independent prognostic factor in human breast cancer.
Molecular carcinogenesis 1994;11(4):189-91.
1994: Latil A; Baron J C; Cussenot O; Fournier G; Boccon-Gibod L; Le Duc A; Lidereau R
Oncogene amplifications in early-stage human prostate carcinomas.
International journal of cancer. Journal international du cancer 1994;59(5):637-8.
1994: Champème M H; Bièche I; Hacène K; Lidereau R
Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(9):900-5.
1994: Latil A; Baron J C; Cussenot O; Fournier G; Soussi T; Boccon-Gibod L; Le Duc A; Rouëssé J; Lidereau R
Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q.
Genes, chromosomes & cancer 1994;11(2):119-25.
1994: Bièche I; Champème M H; Lidereau R
A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.
Cancer research 1994;54(16):4274-6.
1994: Bièche I; Champème M H; Matifas F; Cropp C; Callahan R; Lidereau R
[Demonstration of two regions involved in chromosome 1p deletion in breast tumors]
Bulletin du cancer 1994;81(2):108-13.
1994: Scholl S M; Pallud C; Beuvon F; Hacene K; Stanley E R; Rohrschneider L; Tang R; Pouillart P; Lidereau R
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis.
Journal of the National Cancer Institute 1994;86(2):120-6.
1993: Scholl S M; Mosseri V; Tang R; Beuvon F; Palud C; Lidereau R; Pouillart P
Expression of colony-stimulating factor-1 and its receptor (the protein product of c-fms) in invasive breast tumor cells. Induction of urokinase production via this pathway?
Annals of the New York Academy of Sciences 1993;698():131-5.
1993: Bièche I; Champème M H; Matifas F; Cropp C S; Callahan R; Lidereau R
Two distinct regions involved in 1p deletion in human primary breast cancer.
Cancer research 1993;53(9):1990-4.
1993: Pallud C; Lidereau R; Beuvon F; Tang R; Pouillart P; Scholl S
[Expression of CSF-1 (colony stimulating factor) and its receptor (c-fms) in breast tumors]
Pathologie-biologie 1993;41(1):30.
1992: Bièche I; Champème M H; Matifas F; Hacène K; Callahan R; Lidereau R
Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer.
Lancet 1992;339(8786):139-43.
1992: Bièche I; Champème M H; Matifas F; Hacène K; Lidereau R
[A new marker of aggressivity of breast cancers: loss of heterozygote on chromosome 7q]
Bulletin du cancer 1992;79(9):865-72.
1992: Champème M H; Bièche I; Latil A; Hacène K; Lidereau R
[Association studies in cancerology: the example of gene L-myc polymorphism associated with the incidence of pulmonary metastases in breast cancers]
Bulletin du cancer 1992;79(12):1149-57.
1992: Bièche I; Lidereau R
[Molecular analysis of breast cancers: recent developments]
Bulletin du cancer 1992;79(12):1115-33.
1990: Spyratos F; Delarue J C; Andrieu C; Lidereau R; Champème M H; Hacène K; Brunet M
Epidermal growth factor receptors and prognosis in primary breast cancer.
Breast cancer research and treatment 1990;17(2):83-9.
1990: Bièche I; Champème M H; Lidereau R
[Cancer of the breast. Genetic alterations and prognostic factors]
Pathologie-biologie 1990;38(7):727-34.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Rosette Lidereau

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Rosette Lidereau (preview)

All Publications